Skip to main content

Table 1 The targets of miR-7 in different tumor types

From: MicroRNA-7: a promising new target in cancer therapy

Tumor type

Target site(s)

Reference(s)

Role of target site

Breast cancer

FAK, PAK1, EGFR, KLF4, HoxB3, SET8

[19, 21, 22, 24–26]

Suppressor

Lung cancer

PA28γ, BCL-2, EGFR, SLC7A5, HuR

[32, 35, 38 39]

Suppressor

Hepatocellular carcinoma

CCNE1, PI3KCD, mTOR, p70S6 K, GSK-3B

[48, 54]

Suppressor

Glioma

EGFR, C-KIT, FAK, ERK, ciRS-7

[42–44, 46]

Suppressor

Colorectal cancer

XRCC2, PAX6, YY1

[49, 52, 53]

Suppressor

Gastric cancer

EGFR, IGF1R

[42, 56]

Suppressor

Acute myelocytic leukemia

TET2

[58]

Suppressor

Urothelium carcinoma

FGFR3

[59]

Suppressor

Cervical cancer

XIAP

[60]

Suppressor

Renal carcinoma

None reported

[61]

Oncogene

Melanoma

IRS-2

[62]

Suppressor

Ovarian cancer

EGFR, ERK

[50]

Suppressor

Oral cancer

RECK

[63]

Oncogene

Neuroblastoma

4-HPR, EGCG

[64]

Suppressor

Pancreatic carcinoma

MAPK

[65]

suppressor

Pleural mesothelioma

None reported

[66]

Suppressor

Schwannoma tumors

EGFR, ACK1, PAK1

[67]

Suppressor

Tongue squamous carcinoma

IGF1R

[68]

Suppressor

  1. FAK focal adhesion kinase, PAK1 p21 activated kinase 1, EGFR epidermal growth factor receptor, KLF4 Krüppel like factor 4, HoxB3 homeobox B3, SET8 SET domain-containing (lysine methyltransferase) 8, PA28γ proteasome activator 28 subunit γ, HuR human antigen R, PI3KCD phosphoinositide 3-kinase catalytic subunit delta, mTOR mammalian target of rapamycin, p70S6 K ribosomal protein S6 kinase, GSK-3β glycogen synthase kinase 3, ciRS-7 circular RNA sponge for miR-7, XRCC2 X-ray repair complementing defective repair in Chinese hamster cells 2, PAX6 paired box 6, YY1 Yin Yang 1, IGF1R insulin-like growth factor 1 receptor, TET2 tet methylcytosine dioxygenase 2, FGFR3 fibroblast growth factor receptor 3, XIAP X-linked inhibitor of apoptosis protein, IRS-2 insulin receptor substrate 2, RECK reversion-inducing cysteine-rich protein with Kazal motifs, 4-HPR N-(4-hydroxyphenyl) retinamide, EGCG (-)-epigallocatechin-3-gallate, MAPK mitogen-activated protein kinase, ACK1 associated cdc42 kinase 1